18 recruiting, 7 completed, 6 not yet recruiting, 6 unknown. 40 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 40 | Recruiting 18, Completed 7, Not yet recruiting 6, Unknown 6, Enrolling by invitation 2, Withdrawn 1 |
Follow Immunotherapy: new trials by email Literature Review of Immunotherapy trials Research Report on Immunotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Supervised Aerobic Exercise on Biomarkers in Patients With nSCLC Receiving Immunotherapy Exercise - Non-Small Cell Lung Cancer, Aerobic Exercise | Not applicable | Not yet recruiting | Izmir Bakircay University | 78 | 2027-01-04 | 2026-10-21 |
| MRD-Guided Postoperative Surveillance and Adaptive Treatment for Resectable Lung Cancer Adaptive therapy of de-escalation and escalation based on MRD testing and pathological response - Lung Neoplasms, Neoadjuvant Therapy | Not applicable | Recruiting | Peking University People's Hospital | 100 | 2026-08-12 | 2026-10-26 |
| Developing and Testing the Effectiveness of Smart Healthcare Assisted Individualized Symptom Management Education and Home-based Exercise on Frailty, Treatment-related Adverse Events and Quality of Life in Advanced Gastric Cancer Patients Receiving Immunotherapy AI-ISME&HE - Gastric Cancer (GC), Immunotherapy | Not applicable | Not yet recruiting | Taipei Veterans General Hospital, Taiwan | 110 | 2026-07-21 | 2026-07-29 |
| Investigating Real-Time Immunotherapy Symptoms Study Digital remote monitoring intervention, Usual Care - Cancer, Melanoma (Skin Cancer) | Not applicable | Recruiting | University of Pittsburgh | 40 | 2026-06-17 | 2026-08-04 |
| Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event TempTraq, VitalTraq - Cytokine Release Syndrome, Neoplasms | Not applicable | Enrolling by invitation | National Cancer Institute (NCI) | 136 | 2026-05-27 | 2026-06-25 |
| Biofield Therapy for the Support of Immunotherapy-related Symptoms Among Adult Cancer Patients - A Pilot Study Usui Reiki Intervention - Cancer, Immunotherapy | Not applicable | Recruiting | University of California, Irvine | 12 | 2026-04-20 | 2026-07-10 |
| EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCER Exercise, Control - Non-Small Cell Lung Cancer, Exercise Training | Not applicable | Recruiting | Medical University of Graz | 50 | 2026-04-01 | 2026-06-09 |
| Preoperative Hypofractionated RT + Immunotherapy & Surgery for Retroperitoneal Sarcoma (FUSION-02) ultra-hypofractionated radiotherapy combined with immunotherapy - Soft Tissue Sarcoma (STS), Retroperitoneal Sarcoma | Not applicable | Not yet recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 28 | 2026-02-12 | 2026-02-12 |
| Effect of G-CSF on MDSC and Cancer Stem-cells Interactions in Non-small Cell Lung Cancers (CIRCUIT) Blood sample - Non Small Cell Lung Cancer, Immunotherapy | Not applicable | Not yet recruiting | University Hospital, Bordeaux | 30 | 2025-12-01 | 2025-07-30 |
| Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung Cancer FMD, Regular Diet Plus FMD - Stage IV NSCLC, NSCLC | Not applicable | Recruiting | VA Office of Research and Development | 66 | 2025-10-27 | 2025-11-10 |
| Lymphocyte Function Testing in Immuno-oncology test immunitaire fonctionnel automatisé VIDAS® STIMM™ T RUO - Immunotherapy, Advanced Solid Tumor Malignancies | Not applicable | Not yet recruiting | Centre Leon Berard | 100 | 2025-09-23 | 2025-09-04 |
| Clinical Study of Chemotherapy and Immunotherapy Combined With Lactobacillus Johnsonii in Patients With Multiple Irresectable Solid Tumors oral Lactobacillus johnsonii (1×10¹¹ CFU, twice daily), Placebo - Immunotherapy, Chemotherapy | Not applicable | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 156 | 2025-09-18 | 2025-09-24 |
| Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer Cemiplimab, Dupilumab - Non-Small Cell Lung Cancer, Immunotherapy | Not applicable | Recruiting | Centre hospitalier de l'Université de Montréal (CHUM) | 24 | 2025-08-19 | 2026-08-17 |
| Study on the Classification of Comprehensive Treatment Effect of Hepatocellular Carcinoma Immunotherapy combined with targeted therapy, Standard treatment plan - Hepatocellular Carcinoma, Immunotherapy | Not applicable | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 100 | 2024-09-01 | 2025-02-10 |
| bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma bTAE-HAIC, Lenvatinib, Sintilimab - Liver Diseases, Hepatocellular Carcinoma | Not applicable | Unknown | Sun Yat-sen University | 30 | 2024-05-20 | 2024-08-09 |
| bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC bTAE-HAIC, Lenvatinib, Camrelizumab - Liver Diseases, Hepatocellular Carcinoma | Not applicable | Unknown | Sun Yat-sen University | 40 | 2024-05-20 | 2024-09-23 |
| Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy CTV omitted or delineated - Advanced Non-Small Cell Squamous Lung Cancer, Radiotherapy | Not applicable | Recruiting | Hubei Cancer Hospital | 134 | 2024-03-13 | 2024-03-15 |
| De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyngeal Carcinoma de-escalated radiotherapy, conventional radiotherapy - Nasopharyngeal Carcinoma, Radiotherapy; Complications | Not applicable | Recruiting | Sun Yat-sen University | 112 | 2024-03-04 | 2024-03-19 |
| Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy CTV omitted or delineated - Non Small Cell Lung Cancer, Locally Advanced | Not applicable | Recruiting | Hubei Cancer Hospital | 134 | 2024-02-08 | 2024-03-15 |
| Toripalimab Combined With Definitive CCRT for LACC Patients Toripalimab, CCRT - Cervical Cancer, Chemoradiotherapy | Not applicable | Recruiting | Ruijin Hospital | 150 | 2024-02-02 | 2024-04-24 |
Showing 20 of 40. Sign in to see all of them.
Carcinoma, Non-Small-Cell Lung (8) · Neoplasms (4) · Carcinoma, Hepatocellular (3) · Melanoma (3) · Motor Activity (3) · Colorectal Neoplasms (2) · Esophageal Neoplasms (2) · Hypersensitivity (2) · Liver Diseases (2) · Pain (2) · Stomach Neoplasms (2) · Urinary Bladder Neoplasms (2) · Uterine Cervical Neoplasms (2) · Bites and Stings (1) · Breast Neoplasms (1)
Neoplasms (20) · Neoplasms by Site (20) · Lung Diseases (9) · Neoplasms by Histologic Type (9) · Respiratory Tract Diseases (9) · Respiratory Tract Neoplasms (9) · Thoracic Neoplasms (9) · Bronchial Neoplasms (8) · Carcinoma, Bronchogenic (8) · Digestive System Diseases (8) · Lung Neoplasms (8) · Digestive System Neoplasms (7) · Pathological Conditions, Signs and Symptoms (7) · Carcinoma (5) · Neoplasms, Glandular and Epithelial (5)
Immunotherapy (3) · Antibodies (2) · Exercise (2) · camrelizumab (2) · lenvatinib (2) · Antineoplastic Agents (1) · Azithromycin (1) · Biopsy (1) · Blood Specimen Collection (1) · Diet (1) · Evaluation Studies as Topic (1) · Fecal Microbiota Transplantation (1) · Flour (1) · Hydroxychloroquine (1) · Nivolumab (1)
Sun Yat-sen University (3) · Hubei Cancer Hospital (2) · Mahidol University (2) · Second Affiliated Hospital, Zhejiang University, School of Medicine (2) · Alkarkh Health Directorate-Baghdad (1) · Ankara Medipol University (1) · Beijing Chao Yang Hospital (1) · Beijing Ditan Hospital (1) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Centre Hospitalier Universitaire, Amiens (1) · Centre Leon Berard (1) · Centre hospitalier de l'Université de Montréal (CHUM) (1) · Erasmus Medical Center (1) · Istituto Clinico Humanitas (1) · Izmir Bakircay University (1)
China (13) · United States (8) · France (3) · Thailand (2) · Turkey (Türkiye) (2) · Austria (1) · Belgium (1) · Canada (1) · Iraq (1) · Italy (1) · Netherlands (1) · Slovenia (1) · Switzerland (1)
Punchama Pacharn, MD (2) · Zhimei Hunag, MD (2) · Ahmed S Abdulamir, PhD (1) · Anita Y Kinney, PhD, RN (1) · Antoine Desilets, MD, MSc (1) · Bart Neyns, MD, PhD (1) · Carissa A Low (1) · Egesta Lopci (1) · Elisabeth Taucher, Dr. Dr. (1) · Fatma D Arslan, MD, Prof. (1)
PMID 27099096, PMID 28029303, PMID 28434660, PMID 33044747, PMID 33600761, PMID 34013969, PMID 35255535, PMID 35709465, PMID 35997729, PMID 36375563, PMID 36398889, PMID 36734509, PMID 37090437, PMID 37162745, PMID 38057662, PMID 38783238, PMID 39938469
2025 (1)